The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission
Open accessAbstract
Executive summary The Stanford–Lancet Commission on the North American Opioid Crisis was formed in response to soaring opioid-related morbidity and mortality in the USA and Canada over the past 25 years. The Commission is supported by Stanford University and brings together diverse Stanford scholars and other leading experts across the USA and Canada, with the goals of understanding the opioid crisis, proposing solutions to the crisis domestically, and attempting to stop its spread internationally. Unlike some other Lancet Commissions, this one focuses on a long-entrenched problem that has already been well characterised, including in several reviews by the National Academies of Sciences, Engineering, and Medicine. This Commission therefore focused on developing a coherent, empirically grounded analysis of the causes of, and solutions, to the opioid crisis. The North American crisis emerged when insufficient regulation of the pharmaceutical and health-care industries enabled a profit-driven quadrupling of opioid prescribing. This prescribing involved a departure from long-established practice norms that prevailed before the mid-1990s—particularly in the expanded prescribing of extremely potent opioids for a broad range of chronic, non-cancer pain conditions. Hundreds of thousands of individuals have fatally overdosed on prescription opioids, and millions more have become addicted to opioids or have been harmed in other ways, either as a result of their own opioid use or someone else’s (eg, disability, family breakdown, crime, unemployment, bereavement). In response to the large pool of people who became addicted to prescription opioids, heroin markets expanded, which further increased morbidity and mortality. As heroin markets became saturated with illicit synthetic opioids, such as fentanyl, an already dire situation became a public health catastrophe, which has only worsened since the onset of the COVID-19 pandemic. Since 1999, more than 600 000 people have died from opioid overdoses in the USA and Canada, and the current rate of mortality in each country exceeds even that of the worst year of the HIV/AIDS epidemic. The first wave of the opioid crisis began in the 1990s, when the long-acting opioid OxyContin and other highpotency opioids were prescribed to an extremely wide array of patients. The first wave inflicted the most harm on white and Indigenous people in both the USA and Canada. An unusually high number of middle-class people and people living in selected rural areas (eg, Appalachia in the USA, the Yukon in Canada) were affected in this wave of the crisis compared with previous epidemics of opioid addiction and overdose. The second wave, as heroin markets became resurgent in response to demand from people addicted to prescription opioids, began around 2010 and led to rapidly rising mortality among African Americans in the USA, and more generally in urban areas in the USA and Canada. These demographic shifts persisted into the third wave of the crisis, which began around 2014 and was characterised by rising addiction and fatal overdoses linked with synthetic opioids such as fentanyl. In 2020, fatal opioid Published Online February 2, 2022 https://doi.org/10.1016/ S0140-6736(21)02252-2
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
The global burden of low back pain: estimates from the Global Burden of Disease 2010 study
Hoy, D., March, L., Brooks, P., Blyth, F., Woolf, A., Bain, C., Williams, G., Smith, E., Vos, T., Barendregt, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204428 · Cited by 3,186
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622
Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016
Dahlhamer, J., Lucas, J., Zelaya, Nahin, R., Mackey, S., DeBar, L., Kerns, R., Von Korff, M., Porter, L., & Helmick, C. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6736a2 · Cited by 2,598
Self-citationHoffman, K. M., Trawalter, S., Axt, J. R., & Oliver, M. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516047113 · Cited by 2,486
US Health Care Spending by Payer and Health Condition, 1996-2016
Dieleman, J. L., Cao, J., Chapin, A., Chen, C., Li, Z., Liu, A., Horst, C., Kaldjian, A., Matyasz, T., Scott, K. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.0734 · Cited by 1,313
Risk factors for adolescent substance abuse and dependence: Data from a national sample.
Kilpatrick, D. G., Acierno, R. E., Saunders, B. A., Resnick, H. S., Best, C. L., & Schnurr, P. P. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.1.19 · Cited by 1,164
Tsang, A., Von Korff, M., Lee, S., Alonso, J., Karam, E., Angermeyer, M. C., Borges, G. L. G., Bromet, E. J., de Girolamo, G., de Graaf, R., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2008.05.005 · Cited by 1,157
Early Childhood Education: Young Adult Outcomes From the Abecedarian Project
Campbell, F. A., Ramey, C. T., Pungello, E., Sparling, J., & Miller-Johnson, S. (2002) · Applied Developmental Science · doi:10.1207/s1532480xads0601_05 · Cited by 1,144
Small wins: Redefining the scale of social problems.
Weick, K. E. (1984) · American Psychologist · doi:10.1037//0003-066x.39.1.40 · Cited by 1,128
Cited by
Shifting drug markets in North America - a global crisis in the making?
Meyer, M., Westenberg, J. N., Jang, K. L., Choi, F., Schreiter, S., Mathew, N., King, C., Lang, U. E., Vogel, M., & Krausz, R. M. (2023) · International Journal of Mental Health Systems · doi:10.1186/s13033-023-00601-x · Cited by 41
“Although prescription opioid-involved deaths rates have remained relatively stable, it is important to remember what role prescription drug-control policies had in shaping the nature of today’s drug markets [5].”
BackgroundTsai, M.-H. M., Chen, L., Baumann, M. H., Canals, M., Javitch, J. A., Lane, J. R., & Shi, L. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00750 · Cited by 27
Bhuiyan, I., Tobias, S., & Ti, L. (2023) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2023.2226312 · Cited by 27
Addiction, Thick Market Externalities, and the Persistence of the Opioid Epidemic
Cutler, D., & Donahoe, J. T. (2024) · doi:10.3386/w32055 · Cited by 13
Estacion, M., Liu, S., Cheng, X., Dib-Hajj, S., & Waxman, S. G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1138556 · Cited by 11
Metadata
- Authors
- Humphreys, K., Shover, C. L., Andrews, C. M., Bohnert, A. S. B., Brandeau, M. L., Caulkins, J. P., Chen, J. H., Cuéllar, M.-F., Hurd, Y. L., Juurlink, D. N., Koh, H. K., Krebs, E. E., Lembke, A., Mackey, S. C., Larrimore Ouellette, L., Suffoletto, B., & Timko, C.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 399
- Issue
- 10324
- Pages
- 555-604
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4210358124
- Cited by
- 421
- References
- 197
- FWCI
- 72.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission. https://app.cochat.ai/papers/10.1016/s0140-6736(21)02252-2
- The paper
- Humphreys, K., Shover, C. L., Andrews, C. M., Bohnert, A. S. B., Brandeau, M. L., Caulkins, J. P., Chen, J. H., Cuéllar, M.-F., Hurd, Y. L., Juurlink, D. N., Koh, H. K., Krebs, E. E., Lembke, A., Mackey, S. C., Larrimore Ouellette, L., Suffoletto, B., & Timko, C. (2022). Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission. The Lancet. https://doi.org/10.1016/s0140-6736(21)02252-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.